Relief Therapeutics Holding AG

Relief Therapeutics Holding AGverified

RLF.SW

Price:

$5.9

Market Cap:

$73.99M

Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action for respiratory indications, which is in Phase 3 clinical trials for treating COVID-19-induced acute respiratory distress syndrome and moderate to severe COVID-19 lu...[Read more]

Industry

Biotechnology

IPO Date

2009-08-26

Stock Exchange

SIX

Ticker

RLF.SW

The Enterprise Value as of November 2024 (TTM) for Relief Therapeutics Holding AG (RLF.SW) is 65.68M

According to Relief Therapeutics Holding AG’s latest financial reports and current stock price. The company's current Enterprise Value is 65.68M. This represents a change of 65.92% compared to the average of 39.58M of the last 4 quarters.

Relief Therapeutics Holding AG (RLF.SW) Historical Enterprise Value (quarterly & annually)

How has RLF.SW Enterprise Value performed in the past?

The mean historical Enterprise Value of Relief Therapeutics Holding AG over the last ten years is 105.59M. The current 65.68M Enterprise Value has changed 6.12% with respect to the historical average. Over the past ten years (40 quarters), RLF.SW's Enterprise Value was at its highest in in the December 2010 quarter at 149.23B. The Enterprise Value was at its lowest in in the September 2010 quarter at 0.

Quarterly (TTM)
Annual

Average

105.59M

Median

32.88M

Minimum

3.71M

Maximum

606.89M

Relief Therapeutics Holding AG (RLF.SW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Relief Therapeutics Holding AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 16.24%

Maximum Annual Enterprise Value = 606.89M

Minimum Annual Increase = -88.26%

Minimum Annual Enterprise Value = 3.71M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202313.14M-88.26%
2022111.95M-38.82%
2021182.99M-69.85%
2020606.89M16.24%
20193.71M-69.73%
201812.27M-40.89%
201720.76M-46.02%
201638.46M14.47%
201533.60M4.48%
201432.16M30.48%

Relief Therapeutics Holding AG (RLF.SW) Average Enterprise Value

How has RLF.SW Enterprise Value performed in the past?

The current Enterprise Value of Relief Therapeutics Holding AG (RLF.SW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

102.69M

5-year avg

183.74M

10-year avg

105.59M

Relief Therapeutics Holding AG (RLF.SW) Enterprise Value vs. Peers

How is RLF.SW’s Enterprise Value compared to its peers?

Relief Therapeutics Holding AG’s Enterprise Value is less than Relief Therapeutics Holding AG (67.98M), less than Meyer Burger Technology AG (233.99M), greater than NRx Pharmaceuticals, Inc. (20.89M), less than Dufry AG (16.48B), greater than Evolva Holding SA (-663323.00),

CompanyEnterprise ValueMarket cap
67.98M$91.29M
233.99M$36.72M
20.89M$14.19M
16.48B$4.51B
-663323.00$6.49M

Build a custom stock screener for Relief Therapeutics Holding AG (RLF.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Relief Therapeutics Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Relief Therapeutics Holding AG (RLF.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Relief Therapeutics Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Relief Therapeutics Holding AG's Enterprise Value?

What is the highest Enterprise Value for Relief Therapeutics Holding AG (RLF.SW)?

What is the 3-year average Enterprise Value for Relief Therapeutics Holding AG (RLF.SW)?

What is the 5-year average Enterprise Value for Relief Therapeutics Holding AG (RLF.SW)?

How does the current Enterprise Value for Relief Therapeutics Holding AG (RLF.SW) compare to its historical average?